Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - NET CHANGE IN CASH
Net Change in Cash ADAP - Adaptimmune Therapeutics plc
37.4 M
LAST VALUE
-35.59%
2 YEAR CAGR
34.28%
5 YEAR CAGR
26.95%
10 YEAR CAGR